Galmed Pharmaceuticals Ltd. (GLMD)
NASDAQ: GLMD · Real-Time Price · USD
2.869
+0.009 (0.33%)
Jan 22, 2025, 12:57 PM EST - Market open
Galmed Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Jan '25 Jan 22, 2025 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 4 | 2 | 13 | 46 | 66 | 122 | |
| Market Cap Growth | 709.34% | -85.53% | -72.40% | -31.12% | -45.72% | -14.89% | |
| Enterprise Value | -13 | -11 | -7 | 4 | 8 | 43 | |
| Last Close Price | 2.87 | 5.46 | 90.00 | 327.60 | 559.80 | 1040.40 | |
| PB Ratio | 0.23 | 0.13 | 0.94 | 1.50 | 1.50 | 1.75 | |
| P/TBV Ratio | 0.56 | 0.13 | 0.94 | 1.50 | 1.50 | 1.75 | |
| Debt / Equity Ratio | - | 0.00 | 0.02 | 0.01 | 0.01 | 0.01 | |
| Quick Ratio | 6.99 | 4.66 | 4.51 | 5.94 | 6.36 | 10.92 | |
| Current Ratio | 7.03 | 4.81 | 4.76 | 6.13 | 6.47 | 11.02 | |
| Return on Equity (ROE) | -37.22% | -50.63% | -81.36% | -86.98% | -50.47% | -25.94% | |
| Return on Assets (ROA) | -21.98% | -28.22% | -41.50% | -46.19% | -29.16% | -16.67% | |
| Return on Capital (ROIC) | -24.96% | -33.98% | -49.50% | -54.44% | -32.90% | -17.69% | |
| Earnings Yield | -146.21% | -379.13% | -141.78% | -71.12% | -43.41% | -16.76% | |
| FCF Yield | -111.18% | -336.62% | -146.85% | -72.07% | -39.73% | -12.24% | |
| Buyback Yield / Dilution | -136.81% | -65.23% | -2.22% | -15.59% | -0.79% | -16.41% | |
| Total Shareholder Return | -136.81% | -65.23% | -2.22% | -15.59% | -0.79% | -16.41% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.